Cleared Traditional

K170223 - Progreat

K170223 is an FDA 510(k) clearance for Progreat, manufactured by Ashitaka Factory of Terumo Corporation. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 177-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2017
Decision
177d
Days
Class 2
Risk

K170223 is an FDA 510(k) clearance for the Progreat. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Ashitaka Factory of Terumo Corporation (Fujinomiya, JP). The FDA issued a Cleared decision on July 21, 2017 after a review of 177 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ashitaka Factory of Terumo Corporation devices

FDA 510(k) Submission Details - K170223

510(k) Number K170223 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2017
Decision Date July 21, 2017
Days to Decision 177 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 125d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 321
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K170223.
Royal Flush Catheter
K171264 · Cook Incorporated · Jan 2018
Langston dual lumen catheter
K170544 · Vascular Solutions, Inc. · Nov 2017
Beacon Tip Torcon NB Advantage Catheter, Slip-Cath Beacon Tip Catheter and Shuttle Select Slip-Cath Catheter, Beacon Tip Centimeter Sizing Catheter, Beacon Tip Cava Vessel Sizing Catheter, Beacon Tip White Vessel Sizing Catheter
K173289 · Cook Incorporated · Nov 2017
White Sizing Catheter, Aurous Centimeter Sizing Catheter, Cava Vessel Sizing Catheter
K162448 · Cook Incorporated · May 2017
Soft-Vu, Mariner, Accu-Vu and AngioOptic Catheters
K161596 · AngioDynamics, Inc. · Apr 2017
Medline Waste Station
K160660 · Medline Industries, Inc. · Jan 2017